Upper Gastrointestinal Bleeding Clinical Trial
Official title:
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS): A Pilot Trial to Evaluate Clinician- and Patient-facing Strategies to Reduce Upper Gastrointestinal Bleeding Risk in Patients on Combination Antithrombotic Therapy
This is a pragmatic, single center, feasibility pilot cluster randomized trial with embedded individual randomization to evaluate implementation strategies to increase the use of evidence-based practices to reduce upper gastrointestinal bleeding risk in patients using combination antithrombotic therapy (including warfarin) and that are managed by the Michigan Medicine anticoagulation monitoring service.
In February 2022, the IRB approved adding a small additional substudy for the collection of exploratory qualitative outcomes only, involving up to 8 primary care physicians. As no data for the primary and secondary outcome measures was collected for this substudy, and all data collection for this group was related to exploratory outcome measures and collected through qualitative interviews with clinicians, no inclusion exclusion criteria specific to the participants in this substudy are listed, nor does the data collection from them show in the study completion date or results data. However, these physicians (n=8) and their patients (n=9) are counted in the actual enrollment total since they were randomized to intervention arms and received study interventions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02537353 -
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip
|
Phase 4 | |
| Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
| Suspended |
NCT03337256 -
Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy
|
N/A | |
| Completed |
NCT04472364 -
HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding
|
N/A | |
| Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
| Recruiting |
NCT00414713 -
Transfusion Requirements in Gastrointestinal (GI) Bleeding
|
Phase 4 | |
| Completed |
NCT03680950 -
Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System
|
N/A | |
| Recruiting |
NCT06077916 -
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
|
N/A | |
| Recruiting |
NCT04902248 -
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
|
N/A | |
| Completed |
NCT02446678 -
Use of PillCam ESO2 in Triaging Patients Present With Upper GIB
|
N/A | |
| Completed |
NCT05631639 -
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
|
N/A | |
| Completed |
NCT02978391 -
UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
|
N/A | |
| Completed |
NCT00045799 -
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
|
Phase 3 | |
| Recruiting |
NCT03090945 -
Pediatric Acute Gastrointestinal Bleeding Registry
|
||
| Recruiting |
NCT06192355 -
Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
|
N/A | |
| Recruiting |
NCT06297954 -
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
|
Phase 3 | |
| Recruiting |
NCT03785080 -
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients
|
N/A | |
| Completed |
NCT03667703 -
Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
|
Phase 4 | |
| Terminated |
NCT02017379 -
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
|
N/A | |
| Completed |
NCT01155401 -
Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
|
N/A |